Synbio Tech. Announced the Establishment of Cooperative Relations with ALSTEM
Synbio Technologies, a leading international synthetic biology service company, recently announced a new partnership with ALSTEM, LLC, a United States biotech company, with the aim of developing various human CRISPR-Cas9 sgRNA libraries. These libraries will provide novel approaches for characterizing target and drug resistance genes of therapeutic significance. Related applications also promise to accelerate new drug development and advance the understanding of essential genes related to cancer. Applied to sgRNA primer chip synthesis technology, these libraries hold significant value of understanding the activity of pluripotent stem cell. These two companies will cooperate in product development for high throughput oligonucleotide synthesis and virus library applications, both with wide ranging potential for life science research.
With its Syno® technology platform as a foundation, Synbio Technologies provides efficient services for next generation recombinant antibody libraries, the synthesis of genomic chromosomes, and advanced DNA data storage capabilities.
Synbio Technologies has established a complete synthetic biology platform from the synthesis of oligonucleotides and DNA fragments to the construction of chromosome genomes. Syno®3.0, the world’s most advanced next generation of synthetic biology technology platform, provides high throughput DNA chip synthesis with exceptionally low cost. At the same time, Synbio Technologies leveraged the Syno® synthetic technology platform, to design and develop an advanced biological technology transformation and application platform, the Synbio GPS platform. In alignment with the central dogma of biology, the platform connects genotype/design and phenotype/application with the new, creation enabling, synotype. Through these “design – creation – application” technologies, Synbio Tech. enables gene discovery, and thereby advances genetic understanding and its potential to improve the individual’s lives.
About ALSTEM, LLC:
Founded in 2012 by a team of scientists with deep experience at academic and industrial institutions, ALSTEM advances possibilities for stem cell research, virus packaging, genome editing, and cell immortalization. ALSTEM products have applications in wide-ranging life science areas including drug discovery, cell therapy, regenerative medicine, personalized medicine, toxicity testing, and metabolism. ALSTEM services extend the capacity and efficiency of research teams at large and small institutions worldwide. ALSTEM provides quick, responsive, expertise, with an unsurpassed value ratio of deliverables to cost. ALSTEM’s accessible scientists have a successful track record, and bring an agile mindset to meeting and exceeding client expectations with quick turnaround times.
ALSTEM puts customer needs at the center of its guiding principles. This allows ALSTEM to become an extension of the customers’ lab, and take a pride of ownership in their contribution toward mutual success.
About Synbio Technologies：
Synbio Technologies is a DNA technology company, focusing on the next generation DNA synthesis and its applications. We have built up the first integrated GPS (Genotype, Phenotype and Synotype) system aimed to a quick and easy translation or reverse translation between “Genotype” and “Phenotype” by using our proprietary “Synotype” platform. The company’s scientific capabilities encompass areas such as DNA engineering, DNA synthesis, genome synthesis, pathway synthesis, synthetic biology, pharmacogenomics, microbiology, translational biology and the applications of synthetic biology. Synbio Technologies’ team has a proven track record regarding translating scientific breakthroughs into cost effective biological solution.
1 Deer Park Drive, Suite L-1
Monmouth Junction, NJ 08852
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Synbio Tech. Announced the Establishment of Cooperative Relations with ALSTEM here
News-ID: 687707 • Views: 260
More Releases from Synbio Technologies
Synbio Technologies and Large Gene Synthesis
An interesting and important aspect of genetic research that has grown drastically in popularity over the last ten to fifteen years is gene synthesis . Gene synthesis can be defined as the construction of a physical genetic sequence from a requested sequence in text format. Gene synthesis allows us, at Synbio Technologies, to manufacture genetic sequences that may not already exist within nature. In addition to the de novo sequences
Synbio Technologies and sgRNA Libraries
Synthetic DNA Library Synthesis Synthetic DNA library synthesis is widely applied mechanism within various fields of research such as: discovery biology, protein engineering, structural biology, and gene expression. All of these fields of scientific research have revolutionized the world we live in today, through various means. One of the more popular discoveries in the genetics research community was the construction of the first synthetic DNA library. A synthetic
Synbio Technologies Revolutionizes DNA Synthesis
DNA Synthesis Definition and Methods DNA synthesis definition DNA synthesis is defined as the process by which copies of nucleic acids are strung together to form a longer DNA sequence within a laboratory setting. DNA synthesis processes DNA oligomers are the foundation of the DNA synthesis process. The essential feature of DNA synthesis is that no naturally isolated DNA is used. This step deviates from the traditional method of studying genetics, by which a
Synbio Technologies and Next Generation DNA Synthesis
Progress in DNA Synthesis Steps Within the last few decades, advancements in methods of sequencing, as well as synthesizing, DNA sequences have improved our capabilities of understanding genomics which has led to improved capability of engineering biological systems. The chemically synthesized DNA oligonucleotides and their assembly constructs contain encoded genes, synthons, circuits, metabolic pathways and even whole genomes. These assemblies have the ability to design, build, and test various research
More Releases for Tech
ESET joins Cybersecurity Tech Accord
It was over thirty years ago that the founders of ESET created the first version of the now globally recognized antimalware product used on over 110 million devices in homes, workplaces and on mobile devices. Their commitment, and that of everyone at ESET, is as strong today as it was back then, which is the reason ESET has partnered with more than thirty other technology companies and joined the Cybersecurity
Global Chemical Milling Market 2018 - Tech-Etch, Orbel, Tech Met
Apex Market Reports, recently published a detailed market research study focused on the “Chemical Milling Market” across the global, regional and country level. The report provides 360° analysis of “Chemical Milling Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Chemical Milling on
TELERAD TECH Private Limited
TELERAD TECH Private Limited Telerad Tech has been founded by a group of technology innovators and eminent radiologists with the focus to develop products and solutions to address the gaps and needs of Healthcare IT in general, and radiology automation systems in particular. Having partnered with leading a tele-radiology institute and led by technologists with background in developing and deploying automated solutions, Telerad Tech has the best mix of domain understanding
2nd Annual Power Tech Africa
In a region like sub-Saharan Africa where, 600 million people lack access to electricity, clean renewable energy has the potential to greatly boost the quality of life, economic development as well as environmental sustainability. Various developing nations are investing in renewable energy. Global investment in renewable has hit $285.9 billion in 2015, but more remains to be done to satisfy the needs of the ever growing population. Kenya with its robust
Algoworks’ Partnership With Tech Giants
Algoworks was recently associated with Cloudera as Cloudera SI partners, among other partnerships that the firm has achieved. The founders of the company shared their glee on coming so far in the duration of ten years. As the co-founder of Algoworks, Ajeet Singh says, “Our acute finesse in CRM technologies like Salesforce has assisted us in becoming the Salesforce registered consulting partners. Our unmatched excellence in ECM technologies also earned us
Tech Support: Influencing IoT Adoption
ReportsWorldwide has announced the addition of a new report title Tech Support: Influencing IoT Adoption to its growing collection of premium market research reports. This report examines the actual and perceived complexities and security risks that may serve as barriers to adoption of smart home and other emerging connected devices. It highlights the impact of these concerns and examines support strategies designed to overcome them. The report forecasts the technical support needs generated